ACADIA Pharmaceuticals, Inc. (ACAD)
27.44
+0.89
(+3.35%)
USD |
NASDAQ |
Dec 05, 16:00
27.44
0.00 (0.00%)
After-Hours: 20:00
ACADIA Pharmaceuticals Shareholders Equity (Quarterly): 917.27M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 466.00M |
| ADMA Biologics, Inc. | 431.19M |
| Aldeyra Therapeutics, Inc. | 49.24M |
| Amicus Therapeutics, Inc. | 230.42M |
| ANI Pharmaceuticals, Inc. | 505.82M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.331B |
| Total Liabilities (Quarterly) | 413.50M |
| Debt to Equity Ratio | 0.0598 |
| Current Ratio | 3.019 |
| Net Debt Paydown Yield | 0.02% |